BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $13 to $10.
BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $13 to $10.